Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1PK8
|
||||
Drug Name |
N-(((cis)-4-(4-(dimethylamino)-5-methylpyrimidin-2-ylamino)cyclohexyl)methyl)-3,4-difluorobenzamide
|
||||
Synonyms |
CHEMBL577904
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C21H27F2N5O
|
||||
Canonical SMILES |
CN(C)c1nc(N[C@@H]2CC[C@H](CNC(=O)c3ccc(F)c(F)c3)CC2)ncc1C
|
||||
InChI |
InChI=1S/C21H27F2N5O/c1-13-11-25-21(27-19(13)28(2)3)26-16-7-4-14(5-8-16)12-24-20(29)15-6-9-17(22)18(23)10-15/h6,9-11,14,16H,4-5,7-8,12H2,1-3H3,(H,24,29)(H,25,26,27)/t14-,16+
|
||||
InChIKey |
NFQWOMAFZMZYOX-FZNQNYSPSA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.